St. Louis University Cancer Center — St Louis, Missouri

St. Louis University Cancer Center is a clinical research site located in St Louis, Missouri, United States 63110.

Crixeo Health Trust Score: 73/100 (FAIR). This profile has not yet been claimed by the site owner.

St. Louis University Cancer Center has participated in 7 clinical trials.

Therapeutic areas: Peripheral T-cell Lymphoma, Chronic Myelogenous Leukemia in Chronic Phase, Gastric Cancer.

Sponsors: Acrotech Biopharma Inc., Novartis Pharmaceuticals, Taiho Oncology, Inc..

Sponsor Feasibility Report

Trust Score: 73/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for St. Louis University Cancer Center?

St. Louis University Cancer Center has a Crixeo Trust Score of 73/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has St. Louis University Cancer Center conducted?

St. Louis University Cancer Center has 7 clinical trials on record. Their work covers Peripheral T-cell Lymphoma, Chronic Myelogenous Leukemia in Chronic Phase, Gastric Cancer.

Is St. Louis University Cancer Center accredited by Crixeo Health?

Yes — St. Louis University Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about St. Louis University Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.